Inspire Medical Systems, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Inspire Medical Systems, Inc. (INSP) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.35 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-03
- Inspire Medical Systems, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 3.35M shares, a 24.51% increase year-over-year.
- Inspire Medical Systems, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.65M shares, a 51.34% increase year-over-year.
- Inspire Medical Systems, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 2.38M shares, a 34.01% increase year-over-year.
- Inspire Medical Systems, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 2.69M shares, a 63.97% increase year-over-year.
- Inspire Medical Systems, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.94M shares, a 25.70% increase from fiscal 2024.
- Inspire Medical Systems, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.54M shares, a 41.70% decline from fiscal 2023.
- Inspire Medical Systems, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 2.65M shares, a 4.93% decline from fiscal 2022.
- Inspire Medical Systems, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.79M shares, a 5.17% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.35M shares 10-Q · filed 2026-08-03 | 2.32M shares 10-Q · filed 2026-08-03 | |||||
| 2026-03-31 | 2.65M shares 10-Q · filed 2026-05-04 | ||||||
| 2025-12-31 | 1.94M shares 10-K · filed 2026-02-13 | ||||||
| 2025-09-30 | 2.38M shares 10-Q · filed 2025-11-03 | 1.95M shares 10-Q · filed 2025-11-03 | |||||
| 2025-06-30 | 2.69M shares 10-Q · filed 2026-08-03 | 2.44M shares 10-Q · filed 2026-08-03 | |||||
| 2025-03-31 | 1.75M shares 10-Q · filed 2026-05-04 | ||||||
| 2024-12-31 | 1.54M shares 10-K · filed 2026-02-13 | ||||||
| 2024-09-30 | 1.78M shares 10-Q · filed 2025-11-03 | 1.57M shares 10-Q · filed 2025-11-03 | 2.99M shares 10-Q · filed 2024-11-04 | ||||
| 2024-06-30 | 1.64M shares 10-Q · filed 2025-08-04 | 2.29M shares 10-Q · filed 2025-08-04 | 3.01M shares 10-Q · filed 2024-08-06 | ||||
| 2024-03-31 | 3.06M shares 10-Q · filed 2025-05-05 | ||||||
| 2023-12-31 | 2.65M shares 10-K · filed 2026-02-13 | ||||||
| 2023-09-30 | 2.87M shares 10-Q · filed 2024-11-04 | ||||||
| 2023-06-30 | 2.90M shares 10-Q · filed 2024-08-06 | ||||||
| 2023-03-31 | 3.00M shares 10-Q · filed 2024-05-07 | ||||||
| 2022-12-31 | 2.79M shares 10-K · filed 2025-02-10 | ||||||
| 2022-09-30 | 2.90M shares 10-Q · filed 2023-11-07 | 2.98M shares 10-Q · filed 2022-11-01 | |||||
| 2022-06-30 | 2.84M shares 10-Q · filed 2023-08-01 | 2.92M shares 10-Q · filed 2022-08-02 | |||||
| 2022-03-31 | 2.83M shares 10-Q · filed 2023-05-02 | 2.91M shares 10-Q · filed 2022-05-03 | |||||
| 2021-12-31 | 2.65M shares 10-K · filed 2024-02-09 | ||||||
| 2021-09-30 | 2.69M shares 10-Q · filed 2022-11-01 | ||||||
| 2021-06-30 | 2.75M shares 10-Q · filed 2022-08-02 | ||||||
| 2021-03-31 | 2.76M shares 10-Q · filed 2022-05-03 | ||||||
| 2020-12-31 | 2.86M shares 10-K · filed 2023-02-10 | ||||||
| 2020-09-30 | 2.51M shares 10-Q · filed 2021-11-02 | ||||||
| 2020-06-30 | 2.65M shares 10-Q · filed 2021-08-03 | ||||||
| 2020-03-31 | 2.63M shares 10-Q · filed 2021-05-04 | ||||||
| 2019-12-31 | 2.84M shares 10-K · filed 2022-02-15 | ||||||
| 2019-09-30 | 2.34M shares 10-Q · filed 2019-11-05 | ||||||
| 2019-06-30 | 2.37M shares 10-Q · filed 2020-08-04 | ||||||
| 2019-03-31 | 2.70M shares 10-Q · filed 2020-05-05 | ||||||
| 2018-12-31 | 2.75M shares 10-K · filed 2021-02-24 | ||||||
| 2018-09-30 | 2.28M shares 10-Q · filed 2019-11-05 | ||||||
| 2018-06-30 | 2.30M shares 10-Q · filed 2019-08-06 | ||||||
| 2018-03-31 | 14.74M shares 10-Q · filed 2019-05-07 | ||||||
| 2017-12-31 | 14.61M shares 10-K · filed 2020-02-25 | ||||||
| 2017-09-30 | 14.25M shares 10-Q · filed 2018-11-06 | ||||||
| 2017-06-30 | 14.27M shares 10-Q · filed 2018-08-07 | ||||||
| 2017-03-31 | 14.23M shares 10-Q · filed 2018-06-07 | ||||||
| 2016-12-31 | 11.26M shares 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |